Quote:
Originally Posted by 'Hamas' Jenkins
Coagulopathies have been an unfortunate issue for many seriously ill COVID patients, and microvascular thrombosis has been indicated as a precipitating factor for respiratory failure among patients that die. All admitted patients should at the very least receive prophylactic doses of low molecular weight heparins (like enoxaparin) if they don't have a contraindication.
Those that demonstrate VTE/PE will need therapeutic doses and will likely be at increased risk of thrombosis for several weeks/months after discharge.
|
Thanks for explaining it using the right words I know my wife said but I am unable to remember or spell.
/she does disability determination so is more use than me to using the jargon
__________________
"Most of us can, as we choose, make of this world either a palace or a prison."
–John Lubbock
|